Predictive value of eTag dimerization assay in patients with metastatic colorectal cancer treated with erlotinib.

被引：0
|
作者：
Oza, AM
Townsley, CA
Pond, G
Singh, S
Siu, LL
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Aclara Inc, Mountain View, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：865S / 865S
页数：1
相关论文
共 50 条
  • [21] Prognostic and Predictive Value of Mucinous Adenocarcinomas in Colorectal Cancer Patients Treated With Chemotherapy and Targeted Therapy
    Mekenkamp, L. J. M.
    Heesterbeek, C. J.
    Koopman, M.
    Teerenstra, S.
    Venderbosch, S.
    Punt, C. J. A.
    Nagtegaal, I. D.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S396 - S396
  • [22] Predictive value of EGFR mRNA levels assessed by quantitative RT-PCR in primary tumors of patients treated with cetuximab for metastatic colorectal cancer
    Briasoulis, E. C.
    Papamichael, D.
    Tzachanis, D.
    Christodoulou, C.
    Samantas, E.
    Razis, E.
    Papakostas, P.
    Bakoyiannis, C.
    Wirtz, R. M.
    Kalogeras, K. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Predictive value of D-dimer and LDH levels in response to chemotherapy in metastatic colorectal cancer patients
    Er, O.
    Inanc, M.
    Ozkan, M.
    Dogu, G. G.
    Dikilitas, M.
    Ozturk, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Development of brain metastases in stage III/IV non-small cell lung cancer patients treated with or without erlotinib.
    Liu, Jing
    Kong, Li
    Meng, Xue
    Yue, Jinbo
    Sun, Xindong
    Yu, Jinming
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Sex as a predictive factor in metastatic colorectal cancer treated with bevacizumab containing chemotherapy
    Jeong, Jae-Heon
    Baek, Sun Kyung
    Chae, Jung Min
    Lee, Gil Yeon
    Park, Sun Jin
    Kim, Si-Young
    Yoon, Hwi Joong
    Cho, Kyung Sam
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] EXPLORATORY ANALYSIS OF A PROGNOSIS PREDICTIVE MODEL FOR METASTATIC COLORECTAL CANCER TREATED WITH CHEMOTHERAPY
    Tanaka, Mamoru
    Kumagai, Hozumi
    Kishimoto, Junji
    Mukaide, Satomi
    Oda, Hisanobu
    Mitsugi, Kenji
    Makiyama, Akitaka
    Komoda, Masato
    Kusaba, Hitoshi
    Baba, Eishi
    ANNALS OF ONCOLOGY, 2014, 25
  • [27] Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102
    Hamauchi, Satoshi
    Yamazaki, Kentaro
    Masuishi, Toshiki
    Kito, Yosuke
    Komori, Azusa
    Tsushima, Takahiro
    Narita, Yukiya
    Todaka, Akiko
    Ishihara, Makoto
    Yokota, Tomoya
    Tanaka, Tsutomu
    Machida, Nozomu
    Kadowaki, Shigenori
    Fukutomi, Akira
    Ura, Takashi
    Onozawa, Yusuke
    Ando, Masashi
    Tajika, Masahiro
    Muro, Kei
    Yasui, Hirofumi
    Mori, Keita
    Taniguchi, Hiroya
    CLINICAL COLORECTAL CANCER, 2017, 16 (01) : 51 - 57
  • [28] Prognostic and predictive value of CA19-9 in metastatic colorectal cancer
    Narita, Yukiya
    Taniguchi, Hiroya
    Komori, Azusa
    Nitta, Sohhei
    Yamaguchi, Kazuhisa
    Kondoh, Chihiro
    Kadowaki, Shigenori
    Takahari, Daisuke
    Ura, Takashi
    Andoh, Masashi
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [29] Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
    C A Townsley
    P Major
    L L Siu
    J Dancey
    E Chen
    G R Pond
    T Nicklee
    J Ho
    D Hedley
    M Tsao
    M J Moore
    A M Oza
    British Journal of Cancer, 2006, 94 : 1136 - 1143
  • [30] Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
    Townsley, CA
    Major, P
    Siu, LL
    Dancey, J
    Chen, E
    Pond, GR
    Nicklee, T
    Ho, J
    Hedley, D
    Tsao, M
    Moore, MJ
    Oza, AM
    BRITISH JOURNAL OF CANCER, 2006, 94 (08) : 1136 - 1143
12345